Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cox

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
Schizophrenia Research|June 24, 2016
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathologyDavid A Cox, Michael G Gottschalk, Hendrik Wesseling, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 23, 2021
A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and OpportunitiesBrooke M Currie, Timothy A Howell, Louis S Matza, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trialElizabeth Barrett-Connor, Jane A Cauley, Pandurang M Kulkarni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 20, 2005
Relationship between osteoporosis and cardiovascular disease in postmenopausal womenLászló B Tankó, Claus Christiansen, David A Cox, et al.
Journal of Interventional Cardiology|April 16, 2011
Two-Year outcomes after utilization of the TAXUS paclitaxel-eluting stent in bifurcations and multivessel stenting in the ARRIVE registriesEmmanouil S Brilakis, John M Lasala, David A Cox, et al.
JACC. Cardiovascular Interventions|September 22, 2012
Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky, Brent T McLaurin, David A Cox, et al.
The American Journal of Medicine|April 20, 2010
Effect of Raloxifene on all-cause mortalityDeborah Grady, Jane A Cauley, John L Stock, et al.
The American Journal of Cardiology|February 8, 2006
Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosisKristine Ensrud, Andrea Riccardo Genazzani, Mary Jane Geiger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2008
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registryJohn M Lasala, David A Cox, David Dobies, et al.
Journal of Interventional Cardiology|February 9, 2011
Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE programPei-Hsiu Huang, Michael Yeung, John M Lasala, et al.
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
Schizophrenia Research|June 24, 2016
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathologyDavid A Cox, Michael G Gottschalk, Hendrik Wesseling, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 23, 2021
A Review of Interventional Trials in Youth-Onset Type 2 Diabetes: Challenges and OpportunitiesBrooke M Currie, Timothy A Howell, Louis S Matza, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 3, 2004
Risk-benefit profile for raloxifene: 4-year data From the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trialElizabeth Barrett-Connor, Jane A Cauley, Pandurang M Kulkarni, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 20, 2005
Relationship between osteoporosis and cardiovascular disease in postmenopausal womenLászló B Tankó, Claus Christiansen, David A Cox, et al.
Journal of Interventional Cardiology|April 16, 2011
Two-Year outcomes after utilization of the TAXUS paclitaxel-eluting stent in bifurcations and multivessel stenting in the ARRIVE registriesEmmanouil S Brilakis, John M Lasala, David A Cox, et al.
JACC. Cardiovascular Interventions|September 22, 2012
Outcomes of patients with prior coronary artery bypass grafting and acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky, Brent T McLaurin, David A Cox, et al.
The American Journal of Medicine|April 20, 2010
Effect of Raloxifene on all-cause mortalityDeborah Grady, Jane A Cauley, John L Stock, et al.
The American Journal of Cardiology|February 8, 2006
Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosisKristine Ensrud, Andrea Riccardo Genazzani, Mary Jane Geiger, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 25, 2008
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registryJohn M Lasala, David A Cox, David Dobies, et al.
Journal of Interventional Cardiology|February 9, 2011
Two-year clinical outcomes with paclitaxel-eluting coronary stents in patients with chronic total occlusions: analysis from the TAXUS ARRIVE programPei-Hsiu Huang, Michael Yeung, John M Lasala, et al.
Pageof 17